Tag: Patient costs

The definition of what constitutes a 'tier 6 drug' is not universal and depends entirely on your specific health insurance plan. For some, it represents the highest-cost specialty medications, while for others, it is a select group of low-cost maintenance drugs. This significant discrepancy underscores the critical importance of reviewing your plan's formulary to determine your out-of-pocket costs accurately.

According to a 2016 study published in *Health Affairs*, Medicare Part D patients paid average copayments more than 10 times higher for certain brand-name “me too” medications compared to their generic therapeutic alternatives. This stark statistic highlights the complex and often counterintuitive pricing of me too drugs within the pharmaceutical marketplace.